Saama Technologies, Inc. (“Saama”) announced today the company’s support for the AWS for Health initiative from Amazon Web Services (AWS).
- Saama’s customized cloud strategy aligned with AWS
- Saama Smart Applications for fast-tracked clinical innovation supported by AWS
- Saama ensures faster, safer clinical development via AWS hosting
CAMPBELL, CA – (July 15, 2021) – Saama Technologies, Inc. (“Saama”) announced today the company’s support for the AWS for Health initiative from Amazon Web Services (AWS). AWS hosts Saama’s award-winning Life Science Analytics Cloud (LSAC), contributing to Saama’s ability to accelerate and simplify the cloud adoption journey for life sciences companies and empower them to meet their complex data management needs.
AWS for Health is an initiative featuring services and solutions from AWS and AWS Partners, built specifically for healthcare, biopharma, and genomics customers. The initiative makes it easier for health customers to select the right tools and partners for their highest-priority workloads across the health ecosystem. For customers looking to accelerate deployments with solution-specific support, AWS for Health also identifies dedicated AWS health industry specialists, AWS Professional Services teams, and leading AWS Partners in each solution area.
Large biopharma often struggle with migrating their data and applications to the cloud and managing their cloud infrastructure and services. LSAC aligns with AWS to help facilitate interoperability and rapid cloud migration. Additionally, Saama’s suite of Smart Applications enables biopharma to resolve analytics challenges associated with their extensive study portfolios, vast data silos, and diverse end-user needs, including quality metrics and reporting, operational optimization, health and disease prediction, population health, and health datasets.
“Saama selects its analytics collaborators based on a rigorous and thorough vetting of their capabilities, security, and ability to support our mission of accelerating clinical trials to speed development and delivery of life-saving drugs,” said Sagar Anisingaraju, Chief Strategy Officer, Saama Technologies. “AWS meets our stringent criteria, and helps enable the success of our customers’ clinical programs.”
For more information visit www.saama.com.
About Saama Technologies, Inc.
Saama is the #1 AI-driven Intelligent Clinical Cloud company, enabling the life sciences industry to conduct faster and safer clinical development and regulatory programs. Today, over 50 biotech companies use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform on more than 1,500 studies, including many of the top 20 pharmaceutical companies. LSAC’s rich applications facilitate an unprecedented, authoritative oversight of comprehensive clinical research data, enabling companies to file New Drug Applications (NDAs) more efficiently and bring drugs to market faster. Discover more at www.saama.com and follow Saama @SaamaTechInc.
Media Contact
Saama Technologies
Gregory T. Simpson
+1.908.313.7467